会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Juvenile safety car seat
    • 少年安全车座
    • US06478377B2
    • 2002-11-12
    • US09737364
    • 2000-12-14
    • Kenzou KassaiKeiji Inoue
    • Kenzou KassaiKeiji Inoue
    • A47C108
    • B60N2/286B60N2/2839B60N2/2866B60N2/2872
    • A juvenile safety car seat has a seat portion and a backrest portion forming a support and defining a support space for supporting a child. A pair of side guards are outwardly movably provided on left and right sides of the backrest portion for protecting the head and the shoulder regions of the child. The lower portions of the side guards, which protect the child's shoulders, have a greater range of outward lateral movement than the upper portions of the side guards, which protect the child's head. A vertical position adjusting mechanism for adjusting the vertical position of the backrest portion is provided between the seat portion and the backrest portion. The car seat can be selectively adjusted to suit the growth state of the child.
    • 少年安全座椅具有形成支撑部的座部和靠背部,并且限定用于支撑儿童的支撑空间。 一对侧护板可靠地设置在靠背部分的左侧和右侧,用于保护儿童的头部和肩部区域。 保护小孩的肩膀的侧护板的下部比保护小孩头部的侧护板的上部具有更大的向外侧向运动范围。 用于调节靠背部分的垂直位置的垂直位置调整机构设置在座椅部分和靠背部分之间。 可以选择性地调整汽车座椅以适应儿童的成长状态。
    • 8. 发明授权
    • Method of detecting bladder cancer
    • 检测膀胱癌的方法
    • US08999296B2
    • 2015-04-07
    • US12988621
    • 2009-04-21
    • Keiji InoueMasahiro IshizukaTohru Tanaka
    • Keiji InoueMasahiro IshizukaTohru Tanaka
    • A61K49/00A61K31/198A61K41/00
    • A61K49/0021A61K41/0061Y10S514/814
    • Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient. A sensitizing detection agent for bladder cancer comprising 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of these is orally or intravenously administered, and a video camera system is inserted via the urethra and a blue light at 380-440 nm is irradiated to observe the red fluorescent part. Further, VLD-M1 is inserted and a blue light at 405 nm is irradiated to observe fluorescence intensity (relative intensity) of the red light part. For oral administration, 20 mg/kg (maximum of 1 g) of ALA is dissolved in 50 mL of a 5% glucose solution prior to the administration.
    • 本发明提供口服或静脉内给药型敏化检测剂,其能够以更高的灵敏度检测膀胱癌,而不会对患者造成疼痛。 通过口服或静脉内施用包含5-氨基乙酰丙酸(ALA),其衍生物或其盐的膀胱癌敏化检测剂,通过尿道插入摄像机系统,并将380-440nm的蓝光 照射以观察红色荧光部分。 此外,插入VLD-M1,照射405nm的蓝色光,以观察红色光部分的荧光强度(相对强度)。 对于口服给药,在施用前将20mg / kg(最多1g)的ALA溶于50mL的5%葡萄糖溶液中。
    • 10. 发明申请
    • METHOD OF DETECTING BLADDER CANCER
    • 检测乳腺癌的方法
    • US20110033386A1
    • 2011-02-10
    • US12988621
    • 2009-04-21
    • Keiji InoueMasahiro Ishizuka
    • Keiji InoueMasahiro Ishizuka
    • A61K49/00A61K31/197A61P35/00
    • A61K49/0021A61K41/0061Y10S514/814
    • Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient. A sensitizing detection agent for bladder cancer comprising 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of these is orally or intravenously administered, and a video camera system is inserted via the urethra and a blue light at 380-440 nm is irradiated to observe the red fluorescent part. Further, VLD-M1 is inserted and a blue light at 405 nm is irradiated to observe fluorescence intensity (relative intensity) of the red light part. For oral administration, 20 mg/kg (maximum of 1 g) of ALA is dissolved in 50 mL of a 5% glucose solution prior to the administration.
    • 本发明提供口服或静脉内给药型敏化检测剂,其能够以更高的灵敏度检测膀胱癌,而不会对患者造成疼痛。 通过口服或静脉内施用包含5-氨基乙酰丙酸(ALA),其衍生物或其盐的膀胱癌敏化检测剂,通过尿道插入摄像机系统,并将380-440nm的蓝光 照射以观察红色荧光部分。 此外,插入VLD-M1,照射405nm的蓝色光,以观察红色光部分的荧光强度(相对强度)。 对于口服给药,在施用前将20mg / kg(最多1g)的ALA溶于50mL的5%葡萄糖溶液中。